scispace - formally typeset
J

Joel Shapiro

Researcher at Erasmus University Rotterdam

Publications -  41
Citations -  3253

Joel Shapiro is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Chemoradiotherapy & Neoadjuvant therapy. The author has an hindex of 22, co-authored 37 publications receiving 2559 citations. Previous affiliations of Joel Shapiro include Rochester General Health System & Utrecht University.

Papers
More filters
Journal ArticleDOI

Prediction of survival in patients with oesophageal or junctional cancer receiving neoadjuvant chemoradiotherapy and surgery

TL;DR: This study aimed to quantify the impact of neoadjuvant chemoradiotherapy (nCRT) and surgery on well established prognostic factors, and to develop and validate a prognostic model.
Journal ArticleDOI

CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow. A clinicopathologic study of 40 patients.

TL;DR: Patients with CD5- B-LPDs with atypical nuclear morphologic features may represent the leukemic phase of MCL, and the termCD5- CLL variant is preferred because of clinical and immunophenotypic differences.
Journal Article

Giant bilateral extra-adrenal myelolipoma.

TL;DR: A case of a giant bilateral extra-adrenal myelolipoma, the first in which both features are present, is reported and is notable for having areas of fibromyxoid degeneration histologically similar to those seen in low-grade fibROMyxoid sarcomas.